Sura Mohammed Aziz's picture

Sura Mohammed Aziz

PhD Candidate
  • E-mailSura.Aziz@uib.no
  • Phone+47 907 01 904
  • Visitor Address
    Haukeland University Hospital, Department of Pathology, Sentralblokken 2nd floor.
    Office phone: 0047 555972516. Cell phone: 0047 90701904.
  • Postal Address
    Postboks 7804
    5020 Bergen

Field of Research: Cancer biomarkers in metastatic breast cancer

Metastasis in breast cancer is the common cause of death in women world wide. The identification of specific biomarkers that could identify certain subgroups of patient and predict the responce of these subgroups to specific type of therapy is quite important. We are focusing in Our Projects to identify certain predictive biomarkers that are associated with the metastatic type of breast cancer.

Academic article
  • Show author(s) (2020). AXL is a driver of stemness in normal mammary gland and breast cancer. iScience. 1-40.
  • Show author(s) (2018). Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 11 pages.
  • Show author(s) (2017). Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma. The journal of pathology. Clinical research. 249-257.
  • Show author(s) (2017). Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PLOS ONE. 1-15.
  • Show author(s) (2017). Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival. Cancer Medicine. 1531-1540.
  • Show author(s) (2016). Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer. PLOS ONE.
  • Show author(s) (2014). Evaluation of Ki67 expression across distinct categories of breast cancer specimens: A Population-based study of matched surgical specimens, core needle biopsies and tissue microarrays. PLOS ONE.
Doctoral dissertation
  • Show author(s) (2017). Biological and clinico-pathologic markers in breast cancer. With focus on histologic features, markers of proliferation and angiogenesis.

More information in national current research information system (CRIStin)

Knutsvik G, Stefansson IM, Aziz S, Arnes J, Eide J, Collett K, Akslen LA (2014) Evaluation of Ki67 Expression across Distinct Categories of Breast Cancer Specimens: A Population-Based Study of Matched Surgical Specimens, Core Needle Biopsies and Tissue Microarrays. PloS one 9:e112121. doi: 10.1371/journal.pone.0112121

Fields of competence